世界のプロゲステロンProg市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Progesterone Prog Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4814
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、プロゲステロンProgのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ソフトカプセル、カプセル、注射、その他）、用途別市場規模（月経異常、月経困難症＆月経前症候群、閉経前障害、脅迫＆習慣性中絶、妊娠）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・プロゲステロンProgの市場動向
・企業の競争状況、市場シェア
・プロゲステロンProgの種類別市場規模（ソフトカプセル、カプセル、注射、その他）
・プロゲステロンProgの用途別市場規模（月経異常、月経困難症＆月経前症候群、閉経前障害、脅迫＆習慣性中絶、妊娠）
・プロゲステロンProgの北米市場規模2016-2027（アメリカ、カナダ）
・プロゲステロンProgのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・プロゲステロンProgのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・プロゲステロンProgの中南米市場規模2016-2027（メキシコ、ブラジル）
・プロゲステロンProgの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、Hubei Dongxin Pharmaceutical、Tianjin Jinyao Pharmaceutical、Zhejiang Xianju Pharmaceutical、Shanghai General Pharmaceutical、Guangzhou Baiyunshan Mingxing Pharmaceutical、Besins Healthcare Benelux、Zhejiang Pharmaceutical、Zhejiang Aisheng Pharmaceutical）
・結論

Progesterone is a natural progesterone secreted by the corpus luteum of ovary, which has a significant morphological effect on the endometrium stimulated by estrogen in vivo, and is necessary for maintaining pregnancy.For the treatment of menstrual disorders, such as amenorrhea and functional uterine bleeding, inadequate luteal function, threatened abortion and habitual abortion (caused by luteal deficiency), premenstrual tension syndrome.

Market Analysis and Insights: Global Progesterone Prog Market
The global Progesterone Prog market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Progesterone Prog market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Progesterone Prog market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Progesterone Prog market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Progesterone Prog market.

Global Progesterone Prog Scope and Market Size
Progesterone Prog market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Progesterone Prog market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Soft Capsule
Capsule
Injection
Other

Segment by Application
Menstrual Disorder
Dysmenorrhea And Premenstrual Syndrome
Premenopausal Disorder
Threatened And Habitual Abortion
Pregnancy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Hubei Dongxin Pharmaceutical
Tianjin Jinyao Pharmaceutical
Zhejiang Xianju Pharmaceutical
Shanghai General Pharmaceutical
Guangzhou Baiyunshan Mingxing Pharmaceutical
Besins Healthcare Benelux

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Progesterone Prog Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Soft Capsule
1.2.3 Capsule
1.2.4 Injection
1.2.5 Other
1.3 Market by Application
1.3.1 Global Progesterone Prog Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Menstrual Disorder
1.3.3 Dysmenorrhea And Premenstrual Syndrome
1.3.4 Premenopausal Disorder
1.3.5 Threatened And Habitual Abortion
1.3.6 Pregnancy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Progesterone Prog Market Perspective (2016-2027)
2.2 Progesterone Prog Growth Trends by Regions
2.2.1 Progesterone Prog Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Progesterone Prog Historic Market Share by Regions (2016-2021)
2.2.3 Progesterone Prog Forecasted Market Size by Regions (2022-2027)
2.3 Progesterone Prog Industry Dynamic
2.3.1 Progesterone Prog Market Trends
2.3.2 Progesterone Prog Market Drivers
2.3.3 Progesterone Prog Market Challenges
2.3.4 Progesterone Prog Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Progesterone Prog Players by Revenue
3.1.1 Global Top Progesterone Prog Players by Revenue (2016-2021)
3.1.2 Global Progesterone Prog Revenue Market Share by Players (2016-2021)
3.2 Global Progesterone Prog Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Progesterone Prog Revenue
3.4 Global Progesterone Prog Market Concentration Ratio
3.4.1 Global Progesterone Prog Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Progesterone Prog Revenue in 2020
3.5 Progesterone Prog Key Players Head office and Area Served
3.6 Key Players Progesterone Prog Product Solution and Service
3.7 Date of Enter into Progesterone Prog Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Progesterone Prog Breakdown Data by Type
4.1 Global Progesterone Prog Historic Market Size by Type (2016-2021)
4.2 Global Progesterone Prog Forecasted Market Size by Type (2022-2027)

5 Progesterone Prog Breakdown Data by Application
5.1 Global Progesterone Prog Historic Market Size by Application (2016-2021)
5.2 Global Progesterone Prog Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Progesterone Prog Market Size (2016-2027)
6.2 North America Progesterone Prog Market Size by Type
6.2.1 North America Progesterone Prog Market Size by Type (2016-2021)
6.2.2 North America Progesterone Prog Market Size by Type (2022-2027)
6.2.3 North America Progesterone Prog Market Size by Type (2016-2027)
6.3 North America Progesterone Prog Market Size by Application
6.3.1 North America Progesterone Prog Market Size by Application (2016-2021)
6.3.2 North America Progesterone Prog Market Size by Application (2022-2027)
6.3.3 North America Progesterone Prog Market Size by Application (2016-2027)
6.4 North America Progesterone Prog Market Size by Country
6.4.1 North America Progesterone Prog Market Size by Country (2016-2021)
6.4.2 North America Progesterone Prog Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Progesterone Prog Market Size (2016-2027)
7.2 Europe Progesterone Prog Market Size by Type
7.2.1 Europe Progesterone Prog Market Size by Type (2016-2021)
7.2.2 Europe Progesterone Prog Market Size by Type (2022-2027)
7.2.3 Europe Progesterone Prog Market Size by Type (2016-2027)
7.3 Europe Progesterone Prog Market Size by Application
7.3.1 Europe Progesterone Prog Market Size by Application (2016-2021)
7.3.2 Europe Progesterone Prog Market Size by Application (2022-2027)
7.3.3 Europe Progesterone Prog Market Size by Application (2016-2027)
7.4 Europe Progesterone Prog Market Size by Country
7.4.1 Europe Progesterone Prog Market Size by Country (2016-2021)
7.4.2 Europe Progesterone Prog Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Progesterone Prog Market Size (2016-2027)
8.2 Asia-Pacific Progesterone Prog Market Size by Type
8.2.1 Asia-Pacific Progesterone Prog Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Progesterone Prog Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Progesterone Prog Market Size by Type (2016-2027)
8.3 Asia-Pacific Progesterone Prog Market Size by Application
8.3.1 Asia-Pacific Progesterone Prog Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Progesterone Prog Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Progesterone Prog Market Size by Application (2016-2027)
8.4 Asia-Pacific Progesterone Prog Market Size by Region
8.4.1 Asia-Pacific Progesterone Prog Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Progesterone Prog Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Progesterone Prog Market Size (2016-2027)
9.2 Latin America Progesterone Prog Market Size by Type
9.2.1 Latin America Progesterone Prog Market Size by Type (2016-2021)
9.2.2 Latin America Progesterone Prog Market Size by Type (2022-2027)
9.2.3 Latin America Progesterone Prog Market Size by Type (2016-2027)
9.3 Latin America Progesterone Prog Market Size by Application
9.3.1 Latin America Progesterone Prog Market Size by Application (2016-2021)
9.3.2 Latin America Progesterone Prog Market Size by Application (2022-2027)
9.3.3 Latin America Progesterone Prog Market Size by Application (2016-2027)
9.4 Latin America Progesterone Prog Market Size by Country
9.4.1 Latin America Progesterone Prog Market Size by Country (2016-2021)
9.4.2 Latin America Progesterone Prog Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Progesterone Prog Market Size (2016-2027)
10.2 Middle East & Africa Progesterone Prog Market Size by Type
10.2.1 Middle East & Africa Progesterone Prog Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Progesterone Prog Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Progesterone Prog Market Size by Type (2016-2027)
10.3 Middle East & Africa Progesterone Prog Market Size by Application
10.3.1 Middle East & Africa Progesterone Prog Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Progesterone Prog Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Progesterone Prog Market Size by Application (2016-2027)
10.4 Middle East & Africa Progesterone Prog Market Size by Country
10.4.1 Middle East & Africa Progesterone Prog Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Progesterone Prog Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Progesterone Prog Introduction
11.1.4 Merck Revenue in Progesterone Prog Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Hubei Dongxin Pharmaceutical
11.2.1 Hubei Dongxin Pharmaceutical Company Details
11.2.2 Hubei Dongxin Pharmaceutical Business Overview
11.2.3 Hubei Dongxin Pharmaceutical Progesterone Prog Introduction
11.2.4 Hubei Dongxin Pharmaceutical Revenue in Progesterone Prog Business (2016-2021)
11.2.5 Hubei Dongxin Pharmaceutical Recent Development
11.3 Tianjin Jinyao Pharmaceutical
11.3.1 Tianjin Jinyao Pharmaceutical Company Details
11.3.2 Tianjin Jinyao Pharmaceutical Business Overview
11.3.3 Tianjin Jinyao Pharmaceutical Progesterone Prog Introduction
11.3.4 Tianjin Jinyao Pharmaceutical Revenue in Progesterone Prog Business (2016-2021)
11.3.5 Tianjin Jinyao Pharmaceutical Recent Development
11.4 Zhejiang Xianju Pharmaceutical
11.4.1 Zhejiang Xianju Pharmaceutical Company Details
11.4.2 Zhejiang Xianju Pharmaceutical Business Overview
11.4.3 Zhejiang Xianju Pharmaceutical Progesterone Prog Introduction
11.4.4 Zhejiang Xianju Pharmaceutical Revenue in Progesterone Prog Business (2016-2021)
11.4.5 Zhejiang Xianju Pharmaceutical Recent Development
11.5 Shanghai General Pharmaceutical
11.5.1 Shanghai General Pharmaceutical Company Details
11.5.2 Shanghai General Pharmaceutical Business Overview
11.5.3 Shanghai General Pharmaceutical Progesterone Prog Introduction
11.5.4 Shanghai General Pharmaceutical Revenue in Progesterone Prog Business (2016-2021)
11.5.5 Shanghai General Pharmaceutical Recent Development
11.6 Guangzhou Baiyunshan Mingxing Pharmaceutical
11.6.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Company Details
11.6.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Business Overview
11.6.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Progesterone Prog Introduction
11.6.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Revenue in Progesterone Prog Business (2016-2021)
11.6.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Recent Development
11.7 Besins Healthcare Benelux
11.7.1 Besins Healthcare Benelux Company Details
11.7.2 Besins Healthcare Benelux Business Overview
11.7.3 Besins Healthcare Benelux Progesterone Prog Introduction
11.7.4 Besins Healthcare Benelux Revenue in Progesterone Prog Business (2016-2021)
11.7.5 Besins Healthcare Benelux Recent Development
11.8 Zhejiang Pharmaceutical
11.8.1 Zhejiang Pharmaceutical Company Details
11.8.2 Zhejiang Pharmaceutical Business Overview
11.8.3 Zhejiang Pharmaceutical Progesterone Prog Introduction
11.8.4 Zhejiang Pharmaceutical Revenue in Progesterone Prog Business (2016-2021)
11.8.5 Zhejiang Pharmaceutical Recent Development
11.9 Zhejiang Aisheng Pharmaceutical
11.9.1 Zhejiang Aisheng Pharmaceutical Company Details
11.9.2 Zhejiang Aisheng Pharmaceutical Business Overview
11.9.3 Zhejiang Aisheng Pharmaceutical Progesterone Prog Introduction
11.9.4 Zhejiang Aisheng Pharmaceutical Revenue in Progesterone Prog Business (2016-2021)
11.9.5 Zhejiang Aisheng Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Progesterone Prog Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Soft Capsule
Table 3. Key Players of Capsule
Table 4. Key Players of Injection
Table 5. Key Players of Other
Table 6. Global Progesterone Prog Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Progesterone Prog Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Progesterone Prog Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Progesterone Prog Market Share by Regions (2016-2021)
Table 10. Global Progesterone Prog Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Progesterone Prog Market Share by Regions (2022-2027)
Table 12. Progesterone Prog Market Trends
Table 13. Progesterone Prog Market Drivers
Table 14. Progesterone Prog Market Challenges
Table 15. Progesterone Prog Market Restraints
Table 16. Global Progesterone Prog Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Progesterone Prog Market Share by Players (2016-2021)
Table 18. Global Top Progesterone Prog Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progesterone Prog as of 2020)
Table 19. Ranking of Global Top Progesterone Prog Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Progesterone Prog Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Progesterone Prog Product Solution and Service
Table 23. Date of Enter into Progesterone Prog Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Progesterone Prog Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Progesterone Prog Revenue Market Share by Type (2016-2021)
Table 27. Global Progesterone Prog Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Progesterone Prog Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Progesterone Prog Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Progesterone Prog Revenue Market Share by Application (2016-2021)
Table 31. Global Progesterone Prog Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Progesterone Prog Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Progesterone Prog Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Progesterone Prog Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Progesterone Prog Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Progesterone Prog Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Progesterone Prog Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Progesterone Prog Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Progesterone Prog Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Progesterone Prog Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Progesterone Prog Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Progesterone Prog Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Progesterone Prog Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Progesterone Prog Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Progesterone Prog Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Progesterone Prog Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Progesterone Prog Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Progesterone Prog Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Progesterone Prog Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Progesterone Prog Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Progesterone Prog Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Progesterone Prog Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Progesterone Prog Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Progesterone Prog Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Progesterone Prog Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Progesterone Prog Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Progesterone Prog Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Progesterone Prog Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Progesterone Prog Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Progesterone Prog Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Progesterone Prog Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Progesterone Prog Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Progesterone Prog Product
Table 66. Merck Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Hubei Dongxin Pharmaceutical Company Details
Table 69. Hubei Dongxin Pharmaceutical Business Overview
Table 70. Hubei Dongxin Pharmaceutical Progesterone Prog Product
Table 71. Hubei Dongxin Pharmaceutical Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 72. Hubei Dongxin Pharmaceutical Recent Development
Table 73. Tianjin Jinyao Pharmaceutical Company Details
Table 74. Tianjin Jinyao Pharmaceutical Business Overview
Table 75. Tianjin Jinyao Pharmaceutical Progesterone Prog Product
Table 76. Tianjin Jinyao Pharmaceutical Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 77. Tianjin Jinyao Pharmaceutical Recent Development
Table 78. Zhejiang Xianju Pharmaceutical Company Details
Table 79. Zhejiang Xianju Pharmaceutical Business Overview
Table 80. Zhejiang Xianju Pharmaceutical Progesterone Prog Product
Table 81. Zhejiang Xianju Pharmaceutical Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 82. Zhejiang Xianju Pharmaceutical Recent Development
Table 83. Shanghai General Pharmaceutical Company Details
Table 84. Shanghai General Pharmaceutical Business Overview
Table 85. Shanghai General Pharmaceutical Progesterone Prog Product
Table 86. Shanghai General Pharmaceutical Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 87. Shanghai General Pharmaceutical Recent Development
Table 88. Guangzhou Baiyunshan Mingxing Pharmaceutical Company Details
Table 89. Guangzhou Baiyunshan Mingxing Pharmaceutical Business Overview
Table 90. Guangzhou Baiyunshan Mingxing Pharmaceutical Progesterone Prog Product
Table 91. Guangzhou Baiyunshan Mingxing Pharmaceutical Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 92. Guangzhou Baiyunshan Mingxing Pharmaceutical Recent Development
Table 93. Besins Healthcare Benelux Company Details
Table 94. Besins Healthcare Benelux Business Overview
Table 95. Besins Healthcare Benelux Progesterone Prog Product
Table 96. Besins Healthcare Benelux Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 97. Besins Healthcare Benelux Recent Development
Table 98. Zhejiang Pharmaceutical Company Details
Table 99. Zhejiang Pharmaceutical Business Overview
Table 100. Zhejiang Pharmaceutical Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 101. Zhejiang Pharmaceutical Recent Development
Table 102. Zhejiang Aisheng Pharmaceutical Company Details
Table 103. Zhejiang Aisheng Pharmaceutical Business Overview
Table 104. Zhejiang Aisheng Pharmaceutical Progesterone Prog Product
Table 105. Zhejiang Aisheng Pharmaceutical Revenue in Progesterone Prog Business (2016-2021) & (US$ Million)
Table 106. Zhejiang Aisheng Pharmaceutical Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Progesterone Prog Market Share by Type: 2020 VS 2027
Figure 2. Soft Capsule Features
Figure 3. Capsule Features
Figure 4. Injection Features
Figure 5. Other Features
Figure 6. Global Progesterone Prog Market Share by Application: 2020 VS 2027
Figure 7. Menstrual Disorder Case Studies
Figure 8. Dysmenorrhea And Premenstrual Syndrome Case Studies
Figure 9. Premenopausal Disorder Case Studies
Figure 10. Threatened And Habitual Abortion Case Studies
Figure 11. Pregnancy Case Studies
Figure 12. Progesterone Prog Report Years Considered
Figure 13. Global Progesterone Prog Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Progesterone Prog Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Progesterone Prog Market Share by Regions: 2020 VS 2027
Figure 16. Global Progesterone Prog Market Share by Regions (2022-2027)
Figure 17. Global Progesterone Prog Market Share by Players in 2020
Figure 18. Global Top Progesterone Prog Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progesterone Prog as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Progesterone Prog Revenue in 2020
Figure 20. Global Progesterone Prog Revenue Market Share by Type (2016-2021)
Figure 21. Global Progesterone Prog Revenue Market Share by Type (2022-2027)
Figure 22. North America Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Progesterone Prog Market Share by Type (2016-2027)
Figure 24. North America Progesterone Prog Market Share by Application (2016-2027)
Figure 25. North America Progesterone Prog Market Share by Country (2016-2027)
Figure 26. United States Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Progesterone Prog Market Share by Type (2016-2027)
Figure 30. Europe Progesterone Prog Market Share by Application (2016-2027)
Figure 31. Europe Progesterone Prog Market Share by Country (2016-2027)
Figure 32. Germany Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Progesterone Prog Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Progesterone Prog Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Progesterone Prog Market Share by Region (2016-2027)
Figure 42. China Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Progesterone Prog Market Share by Type (2016-2027)
Figure 50. Latin America Progesterone Prog Market Share by Application (2016-2027)
Figure 51. Latin America Progesterone Prog Market Share by Country (2016-2027)
Figure 52. Mexico Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Progesterone Prog Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Progesterone Prog Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Progesterone Prog Market Share by Country (2016-2027)
Figure 58. Turkey Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Progesterone Prog Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Merck Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 62. Hubei Dongxin Pharmaceutical Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 63. Tianjin Jinyao Pharmaceutical Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 64. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 65. Shanghai General Pharmaceutical Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 66. Guangzhou Baiyunshan Mingxing Pharmaceutical Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 67. Besins Healthcare Benelux Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 68. Zhejiang Pharmaceutical Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 69. Zhejiang Aisheng Pharmaceutical Revenue Growth Rate in Progesterone Prog Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の化学薬品市場規模・現状・予測（2021年-2027年）

Global Chemical Pharmaceutical Market Size, Status and Forecast 2021-2027
QYR2104Z1263 2021年4月 98Pages
QYResearch社発行の本調査資料では、化学薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口用医薬品、注射用医薬品、外用医薬品、その他）、用途別市場規模（製薬産業、研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の製薬契約製造＆契約市場規模・現状・予測（2021年-2027年）

Global Pharmaceutical Contract Manufacturing and Contract Market Size, Status and Forecast 2021-2027
QYR2104Z4562 2021年4月 130Pages
QYResearch社発行の本調査資料では、製薬契約製造＆契約のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、API、その他）、用途別市場規模（中小企業、大企業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界のプロメストリエン市場規模・現状・予測（2021年-2027年）

Global Promestriene Market Size, Status and Forecast 2021-2027
QYR2104Z4820 2021年4月 99Pages
QYResearch社発行の本調査資料では、プロメストリエンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、膣錠、軟膏、イミキモド、クリーム、座薬、その他）、用途別市場規模（女性生殖器系用治療薬、エストロゲン、抗エストロゲン）、主要地...

世界のウンデシル酸テストステロン（TU）市場規模・現状・予測（2021年-2027年）

Global Testosterone Undecylate (TU) Market Size, Status and Forecast 2021-2027
QYR2104Z5609 2021年4月 98Pages
QYResearch社発行の本調査資料では、ウンデシル酸テストステロン（TU）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、経口）、用途別市場規模（原発性性腺機能低下症、性腺機能低下性性腺機能低下症、遅発性性腺機能低下症）、主要地域別市...

世界のラモセトロン市場規模・現状・予測（2021年-2027年）

Global Ramosetron Market Size, Status and Forecast 2021-2027
QYR2104Z4928 2021年4月 98Pages
QYResearch社発行の本調査資料では、ラモセトロンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、経口）、用途別市場規模（病院、がん研究機関、外来サービスセンター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のスタノゾロール市場規模・現状・予測（2021年-2027年）

Global Stanozolol Market Size, Status and Forecast 2021-2027
QYR2104Z5427 2021年4月 93Pages
QYResearch社発行の本調査資料では、スタノゾロールのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（水性懸濁液、経口錠剤）、用途別市場規模（慢性消耗性疾患、アンドロゲン及び同化ホルモン、手術後重度病気及び消失、小児における老齢及び衰弱及び...

世界のドキシフルリジン市場規模・現状・予測（2021年-2027年）

Global Doxifluridine Market Size, Status and Forecast 2021-2027
QYR2104Z1958 2021年4月 126Pages
QYResearch社発行の本調査資料では、ドキシフルリジンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤、カプセル）、用途別市場規模（代謝抑制剤、ホルモン、抗がん剤、抗生物質）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のミコフェノール酸モフェチル（MMF）市場規模・現状・予測（2021年-2027年）

Global Mycophenolate Mofetil (MMF) Market Size, Status and Forecast 2021-2027
QYR2104Z3989 2021年4月 155Pages
QYResearch社発行の本調査資料では、ミコフェノール酸モフェチル（MMF）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル、局所懸濁液、注射、その他）、用途別市場規模（天疱瘡、水疱性類天疱瘡、全身性エリテマトーデス（SLE）...

世界のブルセアジャバニカオイル市場規模・現状・予測（2021年-2027年）

Global Brucea Javanica Oil Market Size, Status and Forecast 2021-2027
QYR2104Z1018 2021年4月 127Pages
QYResearch社発行の本調査資料では、ブルセアジャバニカオイルのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口液剤、注射剤、カプセル剤）、用途別市場規模（アルキル化剤、ホルモン、抗がん剤、抗生物質）、主要地域別市場規模（北米、アメリカ...

世界のデキストロメトルファン市場規模・現状・予測（2021年-2027年）

Global Dextromethorphan Market Size, Status and Forecast 2021-2027
QYR2104Z1812 2021年4月 128Pages
QYResearch社発行の本調査資料では、デキストロメトルファンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、シロップ）、用途別市場規模（風邪、急性/慢性気管支炎、気管支喘息、咽喉痛、結核（TB））、主要地域別市場規模（北米、アメリカ...

世界の自閉症スペクトラム障害（ASD）診断・治療市場規模・現状・予測（2021年-2027年） Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Over the past few years, with the increased number of infants an…
世界の全般性不安障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global General Anxiety Disorder Therapeutics Market The global General Anxiety Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
世界の自閉症スペクトラム障害市場規模・現状・予測（2021年-2027年） Autism spectrum disorder (ASD) is a neurological and developmental disorder that begins early in childhood and lasts throughout a person's life. It affects how a person acts and interacts with others, communicates, and learns. It includes what used to be known as Asperger syndrome and pervasive deve…
世界の自閉症スペクトラム障害（ASD）治療市場規模・現状・予測（2021年-2027年） Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive and characteristic patterns of behavior and difficulties with social communication and interaction. According to CDC statistics, 1 in every 68 children suffers with autism. Innovative d…
世界の神経皮膚障害市場規模・現状・予測（2021年-2027年） The neurocutaneous syndrome is a group of neurologic disorders of brain, spine, and the peripheral nervous system. These diseases are lifelong conditions that may induce a tumor growth inside the skin, organs, skeletal bones, brain, and spinal cord. These disorders are usually genetic and arise due …